Abstract
The development of arenavirus reverse genetics has provided investigators with a novel and powerful approach for the investigation of the arenavirus molecular and cell biology. The use of cell-based minigenome systems has allowed examining the cis- and trans-acting factors involved in arenavirus replication and transcription, and the identification of novel anti-arenaviral drug targets without requiring the use of live forms of arenaviruses. Likewise, it is now feasible to rescue infectious arenaviruses entirely from cloned cDNAs containing predetermined mutations in their genomes to investigate virus-host interactions and mechanisms of pathogenesis. These advances in arenavirus genetics have also facilitated screens to identify anti-arenaviral drugs and the pursuit of novel strategies to generate live-attenuated arenavirus vaccine candidates. Moreover, the generation of tri-segmented (r3) arenaviruses expressing foreign genes of interest (GOI) has opened the possibility of implementing live-attenuated arenaviruses-based vaccine vector approaches. In this chapter, we will summarize the implementation of plasmid-based reverse genetics techniques for the development of r3 arenaviruses expressing foreign GOI for their implementation as vaccine vectors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Buchmeier MJ, Peter CJ, de la Torre JC (2007) Arenaviridae: the viruses and their replication, vol 2. Fields virology. Lippincott William and Wilkins, Philadelphia, PA
Lee KJ, Novella IS, Teng MN, Oldstone MB, de La Torre JC (2000) NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J Virol 74(8):3470–3477
Strecker T, Eichler R, Meulen J, Weissenhorn W, Dieter Klenk H, Garten W, Lenz O (2003) Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles (corrected). J Virol 77(19):10700–10705
Perez M, Craven RC, de la Torre JC (2003) The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A 100(22):12978–12983. doi:10.1073/pnas.2133782100
Urata S, Noda T, Kawaoka Y, Yokosawa H, Yasuda J (2006) Cellular factors required for Lassa virus budding. J Virol 80(8):4191–4195. doi:10.1128/JVI.80.8.4191-4195.2006
Pinschewer DD, Perez M, Sanchez AB, de la Torre JC (2003) Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein. Proc Natl Acad Sci U S A 100(13):7895–7900. doi:10.1073/pnas.1332709100
Beyer WR, Popplau D, Garten W, von Laer D, Lenz O (2003) Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P. J Virol 77(5):2866–2872
Rojek JM, Sanchez AB, Nguyen NT, de la Torre JC, Kunz S (2008) Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses. J Virol 82(15):7677–7687. doi:10.1128/JVI.00560-08
Lee KJ, Perez M, Pinschewer DD, de la Torre JC (2002) Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles. J Virol 76(12):6393–6397
Ortiz-Riano E, Cheng BY, de la Torre JC, Martinez-Sobrido L (2012) Self-association of lymphocytic choriomeningitis virus nucleoprotein is mediated by its N-terminal region and is not required for its anti-interferon function. J Virol 86(6):3307–3317. doi:10.1128/JVI.05503-11
Ortiz-Riano E, Cheng BY, de la Torre JC, Martinez-Sobrido L (2011) The C-terminal region of lymphocytic choriomeningitis virus nucleoprotein contains distinct and segregable functional domains involved in NP-Z interaction and counteraction of the type I interferon response. J Virol 85(24):13038–13048. doi:10.1128/JVI.05834-11
Pythoud C, Rodrigo WW, Pasqual G, Rothenberger S, Martinez-Sobrido L, de la Torre JC, Kunz S (2012) Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKepsilon. J Virol 86(15):7728–7738. doi:10.1128/JVI.00187-12
Martinez-Sobrido L, Emonet S, Giannakas P, Cubitt B, Garcia-Sastre A, de la Torre JC (2009) Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 83(21):11330–11340. doi:10.1128/JVI.00763-09
Martinez-Sobrido L, Giannakas P, Cubitt B, Garcia-Sastre A, de la Torre JC (2007) Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J Virol 81(22):12696–12703. doi:10.1128/JVI.00882-07
Martinez-Sobrido L, Zuniga EI, Rosario D, Garcia-Sastre A, de la Torre JC (2006) Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 80(18):9192–9199. doi:10.1128/JVI.00555-06
Borrow P, Martinez-Sobrido L, de la Torre JC (2010) Inhibition of the type I interferon antiviral response during arenavirus infection. Viruses 2(11):2443–2480. doi:10.3390/v2112443
Pythoud C, Rothenberger S, Martinez-Sobrido L, de la Torre JC, Kunz S (2015) Lymphocytic choriomeningitis virus differentially affects the virus-induced type I interferon response and mitochondrial apoptosis mediated by RIG-I/MAVS. J Virol 89(12):6240–6250. doi:10.1128/JVI.00610-15
Rodrigo WW, Ortiz-Riano E, Pythoud C, Kunz S, de la Torre JC, Martinez-Sobrido L (2012) Arenavirus nucleoproteins prevent activation of nuclear factor kappa B. J Virol 86(15):8185–8197. doi:10.1128/JVI.07240-11
Igonet S, Vaney MC, Vonrhein C, Bricogne G, Stura EA, Hengartner H, Eschli B, Rey FA (2011) X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation. Proc Natl Acad Sci U S A 108(50):19967–19972. doi:10.1073/pnas.1108910108
Burri DJ, da Palma JR, Kunz S, Pasquato A (2012) Envelope glycoprotein of arenaviruses. Viruses 4(10):2162–2181. doi:10.3390/v4102162
Cao W, Henry MD, Borrow P, Yamada H, Elder JH, Ravkov EV, Nichol ST, Compans RW, Campbell KP, Oldstone MB (1998) Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282(5396):2079–2081
Kunz S, Borrow P, Oldstone MB (2002) Receptor structure, binding, and cell entry of arenaviruses. Curr Top Microbiol Immunol 262:111–137
Kunz S, Sevilla N, McGavern DB, Campbell KP, Oldstone MB (2001) Molecular analysis of the interaction of LCMV with its cellular receptor (alpha)-dystroglycan. J Cell Biol 155(2):301–310. doi:10.1083/jcb.200104103
Radoshitzky SR, Abraham J, Spiropoulou CF, Kuhn JH, Nguyen D, Li W, Nagel J, Schmidt PJ, Nunberg JH, Andrews NC, Farzan M, Choe H (2007) Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446(7131):92–96. doi:10.1038/nature05539
Pasqual G, Rojek JM, Masin M, Chatton JY, Kunz S (2011) Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transport. PLoS Pathog 7(9):e1002232. doi:10.1371/journal.ppat.1002232
Capul AA, Perez M, Burke E, Kunz S, Buchmeier MJ, de la Torre JC (2007) Arenavirus Z-glycoprotein association requires Z myristoylation but not functional RING or late domains. J Virol 81(17):9451–9460. doi:10.1128/JVI.00499-07
Perez M, Greenwald DL, de la Torre JC (2004) Myristoylation of the RING finger Z protein is essential for arenavirus budding. J Virol 78(20):11443–11448. doi:10.1128/JVI.78.20.11443-11448.2004
Strecker T, Maisa A, Daffis S, Eichler R, Lenz O, Garten W (2006) The role of myristoylation in the membrane association of the Lassa virus matrix protein Z. Virol J 3:93. doi:10.1186/1743-422X-3-93
Loureiro ME, D'Antuono A, Levingston Macleod JM, Lopez N (2012) Uncovering viral protein-protein interactions and their role in arenavirus life cycle. Viruses 4(9):1651–1667. doi:10.3390/v4091651
de la Torre JC (2008) Reverse genetics approaches to combat pathogenic arenaviruses. Antiviral Res 80(3):239–250. doi:10.1016/j.antiviral.2008.08.002
Emonet SE, Urata S, de la Torre JC (2011) Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies. Virology 411(2):416–425. doi:10.1016/j.virol.2011.01.013
Cheng BY, Ortiz-Riano E, de la Torre JC, Martinez-Sobrido L (2015) Arenavirus genome rearrangement for the development of live-attenuated vaccines. J Virol. doi:10.1128/JVI.00307-15
Ortiz-Riano E, Cheng BY, de la Torre JC, Martinez-Sobrido L (2012) D471G mutation in LCMV-NP affects its ability to self-associate and results in a dominant negative effect in viral RNA synthesis. Viruses 4(10):2137–2161. doi:10.3390/v4102137
Russier M, Reynard S, Carnec X, Baize S (2014) The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses. J Virol 88(23):13811–13820. doi:10.1128/JVI.01908-14
Reynard S, Russier M, Fizet A, Carnec X, Baize S (2014) Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response. J Virol 88(23):13923–13927. doi:10.1128/JVI.01923-14
Seregin AV, Yun NE, Miller M, Aronson J, Smith JK, Walker AG, Smith JN, Huang C, Manning JT, de la Torre JC, Paessler S (2015) The glycoprotein precursor gene of Junin virus determines the virulence of Romero strain and attenuation of Candid #1 strain in a representative animal model of Argentine Hemorrhagic Fever. J Virol. doi:10.1128/JVI.00104-15
Ortiz-Riano E, Cheng BY, Carlos de la Torre J, Martinez-Sobrido L (2013) Arenavirus reverse genetics for vaccine development. J Gen Virol 94(Pt 6):1175–1188. doi:10.1099/vir.0.051102-0
Cheng BY, Ortiz-Riano E, de la Torre JC, Martinez-Sobrido L (2013) Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells. J Vis Exp 78. doi:10.3791/50662
Cheng BY, Ortiz-Riano E, Nogales A, de la Torre JC, Martinez-Sobrido L (2015) Development of live-attenuated arenavirus vaccines based on codon deoptimization. J Virol. doi:10.1128/JVI.03401-14
Rodrigo WW, de la Torre JC, Martinez-Sobrido L (2011) Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses. J Virol 85(4):1684–1695. doi:10.1128/JVI.02229-10
Emonet SF, Garidou L, McGavern DB, de la Torre JC (2009) Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest. Proc Natl Acad Sci U S A 106(9):3473–3478. doi:10.1073/pnas.0900088106
Popkin DL, Teijaro JR, Lee AM, Lewicki H, Emonet S, de la Torre JC, Oldstone M (2011) Expanded potential for recombinant trisegmented lymphocytic choriomeningitis viruses: protein production, antibody production, and in vivo assessment of biological function of genes of interest. J Virol 85(15):7928–7932. doi:10.1128/JVI.00486-11
Ortiz-Riano E, Ngo N, Devito S, Eggink D, Munger J, Shaw ML, de la Torre JC, Martinez-Sobrido L (2014) Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor. J Virol 88(2):878–889. doi:10.1128/JVI.02275-13
Salvato M, Borrow P, Shimomaye E, Oldstone MB (1991) Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. J Virol 65(4):1863–1869
Nisii C, Castilletti C, Raoul H, Hewson R, Brown D, Gopal R, Eickmann M, Gunther S, Mirazimi A, Koivula T, Feldmann H, Di Caro A, Capobianchi MR, Ippolito G (2013) Biosafety Level-4 laboratories in Europe: opportunities for public health, diagnostics, and research. PLoS Pathog 9(1):e1003105. doi:10.1371/journal.ppat.1003105
Nogales A, Baker SF, Martinez-Sobrido L (2015) Replication-competent influenza A viruses expressing a red fluorescent protein. Virology 476:206–216. doi:10.1016/j.virol.2014.12.006
Flick R, Hobom G (1999) Transient bicistronic vRNA segments for indirect selection of recombinant influenza viruses. Virology 262(1):93–103. doi:10.1006/viro.1999.9895
Vieira Machado A, Naffakh N, Gerbaud S, van der Werf S, Escriou N (2006) Recombinant influenza A viruses harboring optimized dicistronic NA segment with an extended native 5′ terminal sequence: induction of heterospecific B and T cell responses in mice. Virology 345(1):73–87. doi:10.1016/j.virol.2005.09.050
Marschalek A, Finke S, Schwemmle M, Mayer D, Heimrich B, Stitz L, Conzelmann KK (2009) Attenuation of rabies virus replication and virulence by picornavirus internal ribosome entry site elements. J Virol 83(4):1911–1919. doi:10.1128/JVI.02055-08
Garcia-Sastre A, Muster T, Barclay WS, Percy N, Palese P (1994) Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus. J Virol 68(10):6254–6261
Goto H, Muramoto Y, Noda T, Kawaoka Y (2013) The genome-packaging signal of the influenza A virus genome comprises a genome incorporation signal and a genome-bundling signal. J Virol 87(21):11316–11322. doi:10.1128/JVI.01301-13
Liang Y, Hong Y, Parslow TG (2005) cis-Acting packaging signals in the influenza virus PB1, PB2, and PA genomic RNA segments. J Virol 79(16):10348–10355. doi:10.1128/JVI.79.16.10348-10355.2005
Ngo N, Cubitt B, Iwasaki M, de la Torre JC (2015) Identification and mechanism of action of a novel small-molecule inhibitor of arenavirus multiplication. J Virol 89(21):10924–10933. doi:10.1128/JVI.01587-15
Meyer BJ, de la Torre JC, Southern PJ (2002) Arenaviruses: genomic RNAs, transcription, and replication. Curr Top Microbiol Immunol 262:139–157
Buchmeier MJ (2002) Arenaviruses: protein structure and function. Curr Top Microbiol Immunol 262:159–173
Young PR, Howard CR (1983) Fine structure analysis of Pichinde virus nucleocapsids. J Gen Virol 64(Pt 4):833–842
Marsh GA, Rabadan R, Levine AJ, Palese P (2008) Highly conserved regions of influenza a virus polymerase gene segments are critical for efficient viral RNA packaging. J Virol 82(5):2295–2304. doi:10.1128/JVI.02267-07
Kohl A, Lowen AC, Leonard VH, Elliott RM (2006) Genetic elements regulating packaging of the Bunyamwera orthobunyavirus genome. J Gen Virol 87(Pt 1):177–187. doi:10.1099/vir.0.81227-0
Hess RD, Weber F, Watson K, Schmitt S (2012) Regulatory, biosafety and safety challenges for novel cells as substrates for human vaccines. Vaccine 30(17):2715–2727. doi:10.1016/j.vaccine.2012.02.015
Heix J, Grummt I (1995) Species specificity of transcription by RNA polymerase I. Curr Opin Genet Dev 5(5):652–656
Flatz L, Bergthaler A, de la Torre JC, Pinschewer DD (2006) Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA. Proc Natl Acad Sci U S A 103(12):4663–4668. doi:10.1073/pnas.0600652103
Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108(2):193–199
Acknowledgments
Current arenavirus research in LM-S laboratory is funded by the NIH grants R21 AI119775-01, R43 AI119775-01, and R21AI121550-01A1. Research in J.C.T. laboratory is supported by grants RO1 AI047140, RO1 AI077719, and RO1 AI079665.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Martínez-Sobrido, L., de la Torre, J.C. (2017). Development of Recombinant Arenavirus-Based Vaccines. In: Ferran, M., Skuse, G. (eds) Recombinant Virus Vaccines. Methods in Molecular Biology, vol 1581. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6869-5_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6869-5_8
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6867-1
Online ISBN: 978-1-4939-6869-5
eBook Packages: Springer Protocols